Rontis Corporation S.A. (Zug, Switzerland) announces the conclusion of pre-clinical tests on a new drug-coated balloon (DCB). The DCB tested is based on the Cronus® family of PTA OTW (0.035”) balloon dilatation catheters, which have been in the market since year 2010 and are worldwide recognized for their flexibility, combined with the high pressures they…
Rontis Corporation S.A. proudly announces that its medical device manufacturing site of Rontis Hellas in Larisa, Greece has successfully passed the inspection by the US Food and Drug Administration (FDA).
Rontis enters into exclusive distribution agreement with Nipro USA Nipro USA launches first Rontis PTA Balloon Catheter Rontis Corporation S.A. announces that its Swiss subsidiary Rontis AG (Zug, Switzerland) has signed an agreement with Nipro Medical Corporation (Miami, USA), a wholly-owned subsidiary of Nipro Corporation, for the exclusive distribution of the Rontis Cronus™ HP…